All of the ADSs in the offering are to be sold by BioLineRx. JMP Securities is acting as sole book-running manager for the offering.
http://ift.tt/1KxqOl1
http://ift.tt/1KxqOl1
Stem Cell Research News: News on Stem Cell Research continually updated from thousands of sources around from the B Media Network.
No comments:
Post a Comment